Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention
Status:
Completed
Trial end date:
2024-03-25
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the use of single dose fosfomycin and single
dose levofloxacin as pre-urodynamic antibiotic prophylaxis for urinary tract infection
prevention post-urodynamic in patients with lower urinary tract symptoms. The main
question[s] it aims to answer are:
- What is the difference between the effectiveness of administering a single dose of
fosfomycin and levofloxacin prior to the procedure in terms of the incidence rate of
urinary tract infection (UTI) post-urodynamic examination?
- What is the incidence rate of UTI in the administration of single-dose fosfomycin and
levofloxacin prior to the procedure on the incidence rate of UTI post-urodynamic
examination? Participants fulfilling the inclusion criteria will be taken their history
and vital signs and consume either fosfomycin or levofloxacin based on the randomisation
prior to urodynamic procedure. Afterwards, participants will undergo urine analysis 4
days post urodynamic to evaluate if there's any urinary tract infection. If there is any
bacteria present, the sample will be cultured to identify bacteria found in the urine.